Cannabis Science Inc (CBIS) financial statements (2020 and earlier)

Company profile

Business Address 19800 MACARTHUR BLVD., SUITE #300
IRVINE, CA 92612
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0000
Cash and cash equivalents 0000
Receivables 00 0
Inventory, net of allowances, customer advances and progress billings 00 
Inventory 00  
Other undisclosed current assets 1000
Total current assets: 1000
Noncurrent Assets
Property, plant and equipment    0
Long-term investments and receivables 0000
Long-term investments 0000
Intangible assets, net (including goodwill) 10 0
Goodwill  0 0
Intangible assets, net (excluding goodwill) 10 0
Prepaid expense   44
Other undisclosed noncurrent assets 01(3)(4)
Total noncurrent assets: 1110
TOTAL ASSETS: 2211
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 2322
Accounts payable 1100
Accrued liabilities 1221
Employee-related liabilities 00  
Debt 0   
Due to related parties 1000
Other undisclosed current liabilities 212 
Total current liabilities: 4442
Noncurrent Liabilities
Other undisclosed liabilities    2
Total liabilities: 4444
Stockholders' equity
Stockholders' equity attributable to parent, including: (1)(2)(3)(4)
Preferred stock 0000
Common stock 2211
Common stock, share subscribed but unissued, subscriptions receivable (1)(0)  
Additional paid in capital 13712811092
Deferred compensation equity (2)(3)  
Accumulated deficit (138)(128)(109)(93)
Other undisclosed stockholders' equity attributable to parent (0)(0)(4)(4)
Stockholders' equity attributable to noncontrolling interest (1)(1)  
Total stockholders' equity: (2)(3)(3)(4)
TOTAL LIABILITIES AND EQUITY: 2211

Income statement (P&L) ($ in millions)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 0000
Revenue, net    0
Financial services revenue    0
Cost of revenue
(Cost of Goods and Services Sold)
 (0)(7)(4)(1)
Gross profit: 0(7)(4)(1)
Operating expenses (9)(19)(16)(3)
Other undisclosed operating income  741
Operating loss: (9)(19)(16)(3)
Nonoperating expense (1)(0)(1) 
Investment income, nonoperating (1) (0) 
Interest and debt expense (1)(6)(5)(2)
Loss from continuing operations before equity method investments, income taxes: (11)(25)(22)(6)
Other undisclosed loss from continuing operations before income taxes    (0)
Net loss: (11)(25)(22)(6)
Net income attributable to noncontrolling interest 01  
Other undisclosed net income attributable to parent 155 
Net loss attributable to parent: (10)(19)(17)(6)
Other undisclosed net income available to common stockholders, basic 01  
Net loss available to common stockholders, diluted: (10)(19)(17)(6)

Comprehensive Income ($ in millions)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss: (11)(25)(22)(6)
Other comprehensive income (loss)  (0)0 
Comprehensive loss: (11)(25)(22)(6)
Comprehensive income, net of tax, attributable to noncontrolling interest 01  
Other undisclosed comprehensive income, net of tax, attributable to parent 165 
Comprehensive loss, net of tax, attributable to parent: (10)(19)(17)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: